Cathie's Ark Logo
Schrodinger Inc Logo

Combined Holdings of Schrödinger, Inc. (SDGR) - Updated Daily

Software As A ServiceBioinformaticsGenomics
Date
Direction
Shares
Fund Weight
Fund
January 6, 2023
BUY9.178k0.0085%ARKG
January 5, 2023
BUY3.548k0.0033%ARKG
November 9, 2022
BUY64.385k0.0581%ARKG
November 4, 2022
BUY147.747k0.1409%ARKG
November 2, 2022
BUY2.026k0.002%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
0.73%$1.79b
🏋️‍♀️Weight Rank Across All Funds🌏Country
27🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$57.16 - ARKG
6.1%
Description
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.
Website
www.schrodinger.com

Other ETFs That Hold SDGR

Ticker
NameWeight
ARKGARK Genomic Revolution ETF5.25%

Research Notes and Commentary for SDGR